Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

ASX 200 sector wrap: the outlook for CBA, FMG, CSL, BHP Group and NAB

Of Australia’s top three sector indices, the ASX 200 Materials index is the only one in positive territory over the last month.

ASX 200 Source: Bloomberg

ASX 200 sector summary

While the ASX 200 benchmark now trades clearly off its March lows, in the last month the index has struggled, trading flatly in that period.

Illustrating these lacklustre market conditions, of Australia’s top three sectors – materials, financials and healthcare – only the materials index is up over the last month. With that in mind, below we examine the recent news flow that may have contributed to these performance disparities.

CBA, NAB, ANZ and Westpac share prices: provisions climb as earnings fall

With Australia’s big four banks having now wrapped up their latest round of earnings results – investors have significantly improved visibility on the true economic impact of the coronavirus.

All up, the common theme across the big four’s results were lower earnings, significant Covid-19 related provisions; and uncertainty regarding the dividend outlook.

For example, while NAB resolved to pay a significantly lower interim dividend; both Westpac and ANZ deferred their interim dividend payments completely, given the current environment of deep economic uncertainty.

Elsewhere, the banks all booked significant provisions in relation to Covid-19 as part of their latest results releases. For instance, CBA booked a $1.5 billion provision related to the expected future impacts of Covid-19; ANZ booked $1675 million worth of provisions during the half; Westpac booked a $2238 million H1 impairment charge; while NAB’s 'collective provisions now include $2.135 million of forward looking adjustments for anticipated stress,' the bank said.

All up, in the last month, the ASX 200 Financials Index (XFJ) – which makes up ~24.5% of the Australian market – has fallen 3.27%.

Looking forward, Macquarie analysts currently have an Underperform rating on ANZ and a price target of $16.50; an Underperform rating on CBA and a price target of $57.00; an Outperform rating on NAB and a price target of $17.00; and a Neutral rating on Westpac and a price target of $17.00.

Rio Tinto, FMG and BHP remain resilient, share price outlook positive, according to Macquarie

While the banks have materially suffered as a result of the coronavirus, Australia’s large-cap iron ore miners – Rio Tinto, FMG and BHP Group – have been less impacted.

In fact, during the most recent quarter, Rio Tinto saw its iron ore shipments increase by 5% to 72.9 million tonnes, BHP Group saw its iron ore shipments increase by 7% to 60 million tonnes, and FMG saw its iron ore shipments rise 10%, to 42.3 million tonnes.

The common thread amongst all the big three miner’s results was that while demand in many parts of the world had fallen as a result of the coronavirus pandemic, in China, demand for iron ore remained robust.

Speaking of Chinese demand, FMG's chief executive, Elizabeth Gaines said that the firm expects a ‘steady recovery in economic activity in that market;' while Rio Tinto’s management pointed out that that 'Demand for the high-quality iron ores we produce remained strong in Q1 of 2020.’

In the last month, the ASX 200 Materials Index (XMJ) – which makes up 18.6% of the local market – rose 0.83%.

Compared to the big four banks, Macquarie analysts remain bullish on the prospects of Australia's big three miners, retaining Outperform ratings on all three. Overall, the investment bank's analysts have a price target of $36.00 on BHP Group, $104.00 on Rio Tinto and $13.20 on FMG.

CSL share price dips, health care falls

Though CSL already reported its H1 results in February, over the last month, the biotech giant has reaffirmed its FY20 profit guidance as well as revealed a new set of debt facilities, totalling US$750 million.

Moreover, while the CSL share price has fallen 7.52% in the last month, the biotech remains Australia’s largest listed company – touting a market capitalisation close to $140 billion.

Over the last month, the ASX 200 Health Care Index (XHJ) – which makes up 13.7% of the local market – has fallen 3.63%.

Looking forward, Macquarie analysts currently have a Neutral rating and an $311.00 price target on CSL, arguing that 'we see the earnings risk associated with Covid-19/lower plasma volumes as skewed to the downside.’

How to trade financial markets: long and short

What do you make of the current environment: do you see bullish or bearish opportunities? Whatever your opinion, you can trade indices, currencies and equities, including the banks and miners – both LONG or SHORT – with IG’s world-class trading platform now.

For example, to buy (long) or sell (short) the ASX 200 index using CFDs, follow these easy steps:

  1. Create an IG Trading Account or log in to your existing account
  2. Enter ‘ASX 200' in the search bar and select it
  3. Choose your position size
  4. Click on ‘buy’ or ‘sell’ in the deal ticket
  5. Confirm the trade

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Tuesday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.